We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > EPO

News List

Using Epo against COVID-19 worldpharmanews
July 07, 2020
Erythropoietin (Epo) is actually a medication for anaemia. According to researchers at the Max Planck Institute of Experimental Medicine in Göttingen, the doping agent Epo could also be effective against COVID-19.
INSERM leads in patent applications, reports European Patent Office europeanpharmaceuticalreview
March 13, 2020
According to the European Patent Office (EPO), in 2019 the number of patents filed in the pharmaceutical and biotechnology sectors rose for a third consecutive year.
EPO Revokes Regenlab PRP Patent americanpharmaceuticalreview
May 22, 2019
Estar Technologies announced the Opposition Division of the European Patent Office (EPO) has revoked Regen Lab SA (Regenlab)'s platelet rich plasma (PRP) patent in its entirety due to lack of novelty and added matter.
EPO 2016 report shows European patent filings in pharmaceuticals drop by 5% pharmaceutical-technology
March 09, 2017
The European Patent Office (EPO) has revealed in its annual report for 2016 that European patent filings in pharmaceuticals decreased by 5%.